CERA: Seeking a smarter way to monitor glaucoma

Dr George Kong is developing new technology to keep patients out of crowded waiting rooms and make smartphones a vital weapon in the battle...

How COVID-19 is changing the future of eye care

The rapid uptake of telehealth services to stop the spread of coronavirus is adding impetus to research to develop innovative new ways of diagnosing and monitoring patients with eye disease.

Could artificial intelligence be beneficial in screening for eye disease?

Centre for Eye Research Australia (CERA), in conjunction with the University of Melbourne is conducting research to gain a better understanding of how artificial intelligence (AI) influences clinical decision-making by a range of health professionals engaged in diabetic retinopathy (DR) screening.

Hot topics in research: Reticular pseudodrusen

15 CPD Minutes in Australia Researchers believe the presence of reticular pseudodrusen may provide valuable insights into a patient’s likely progression to late stage age-related macular degeneration (AMD).

Artificial intelligence boosts the battle against diabetic eye disease

15 CPD Minutes in Australia Artificial intelligence is being deployed in research to help the 1.3 million Australians with diabetes avoid sight threatening complications.

Promising vitamin B3 glaucoma research

AU: 15 minutes CPD CERA's research is the first clinical study to demonstrate the potential of vitamin B3 as a glaucoma therapy.

WATCH: Research offers hope for glaucoma gene therapy

AU: 15 minutes CPD Researchers have used gene therapy to regenerate damaged optic nerve fibres in a discovery that could lead to new glaucoma treatments in the future.